Dr. Emma Kurz is part of a research team that has found that exercise can help make immunotherapy more effective for pancreatic cancer.
Dr. Andrew Aguirre and other researchers from Dana-Farber and the Broad Institute are looking at the RAS pathway for a new target.
Dr. James Flory wants to establish which diabetes drug works best for pancreatic cancer patients who develop diabetes.
Social worker Angie Heller and caregiver Richard Cohen describe ways patients and loved ones can focus on what matters most after diagnosis.
Dr. Michael Goggins provides results for the CAPS5 pancreatic cancer surveillance and screening study for patients at high risk.